NEO - NeoGenomics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
Total Revenue
378,437
276,741
258,611
244,083
Cost of Revenue
194,414
149,476
138,295
133,704
Gross Profit
184,023
127,265
120,316
110,379
Operating Expenses
Research Development
6,933
3,001
3,636
4,649
Selling General and Administrative
163,584
114,224
113,298
99,692
Total Operating Expenses
170,517
117,225
116,934
104,341
Operating Income or Loss
13,506
10,040
3,382
6,038
Interest Expense
-
6,230
-
-
Total Other Income/Expenses Net
-6,101
14
-1,323
-3,464
Income Before Tax
2,612
3,824
-3,481
-7,424
Income Tax Expense
549
1,184
-2,635
-1,701
Income from Continuing Operations
2,063
2,640
-846
-5,723
Net Income
2,063
2,640
-846
-5,723
Net Income available to common shareholders
2,063
6,088
-11,393
-30,397
Reported EPS
Basic
-
0.07
-0.14
-0.39
Diluted
-
0.07
-0.14
-0.39
Weighted average shares outstanding
Basic
-
85,618
79,426
77,542
Diluted
-
91,568
79,426
77,542
EBITDA
-
31,772
25,973
29,247